Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Regulation FD disclosure
  3. 8-K Event Executive or director change
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 8-K Event Executive or director change
  9. 4 Shares withheld for taxes Chief R&D Officer gave up 7,525 shares (to pay taxes)
  10. 8-K Event Other events
  11. 4 Grant or award Director acquired 653 shares (grant or award)
  12. 8-K Event Executive or director change
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations · Regulation FD disclosure · Other events
  15. 8-K Event Regulation FD disclosure
  16. 8-K Event Results of operations · Regulation FD disclosure
  17. 8-K Event Regulation FD disclosure
  18. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,461 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief R&D Officer gave up 6,096 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Financial Officer gave up 2,461 shares (to pay taxes)

Page 8 of 99 · 1,967 filings